{"id":3535,"date":"2020-08-05T08:59:55","date_gmt":"2020-08-05T07:59:55","guid":{"rendered":"https:\/\/cn-bio.com\/?p=3535"},"modified":"2022-08-19T07:02:27","modified_gmt":"2022-08-19T07:02:27","slug":"cn-bio-senior-appointments-support-international-commercial-development","status":"publish","type":"post","link":"https:\/\/cn-bio.com\/cn-bio-senior-appointments-support-international-commercial-development\/","title":{"rendered":"CN Bio makes key senior appointments to support international commercial development"},"content":{"rendered":"

Appointments include James Craven as Chief Commercial Officer and Brian Manning as US Head of Sales <\/em><\/p>\n

Cambridge, UK, 05 August 2020:<\/strong> CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced the appointments of James Craven as Chief Commercial Officer and Dr. Brian Manning as US Head of Sales. At the same time, Dr. Sarah Payne joins the Company as Product Marketing Manager. Following the completion of a $9 million USD funding round in February, the appointments will help drive CN Bio\u2019s sales and business strategy, with a focus on further developing its US customer base, the Company\u2019s key market.<\/p>\n

James has over 20 years\u2019 commercial experience within the life sciences sector and has a wealth of expertise in marketing laboratory instruments. James joins CN Bio from Brooks Life Sciences, where he developed and managed relationships with global pharmaceutical companies as Director of Market Strategy and Commercial Delivery. He has held senior management positions at TTP Labtech and Titian Software. As CN Bio\u2019s Chief Commercial Officer, James will harness the Company\u2019s 10 years of established expertise, to expand its visibility and drive sales of products and services, including the PhysioMimix\u00ae platform.<\/p>\n

Brian has significant business development experience across the pharma and biotech industries in the US, Europe and Asia, including in his most recent role at InSphero, as Senior Director of Business Development. Prior, Brian has held key positions at Pfizer, DiscoverX, GenScript, and Cyclofluidic, where he was Vice President of Business Development in North America. In his new role as US Head of Sales, Brian will be responsible for cultivating CN Bio\u2019s commercial and scientific relationships, including building out the Company\u2019s US presence and extensive application support, internationally.<\/p>\n

Sarah joins CN Bio as Product Marketing Manager, where she will harness her substantial experience in combined sales, product management and marketing to shape the Company\u2019s expanding technology portfolio in all application areas. Sarah has previously held senior marketing roles at leading life science companies, including SPT Labtech, most recently, and GE Healthcare.<\/p>\n

James Craven, Chief Commercial Officer, CN Bio, commented: <\/strong>\u201cAs an established and trusted cell culture company, already working with over eight of the top 20 pharma companies globally, I\u2019m enthusiastic to be part of CN Bio\u2019s team, to build its strategic partnerships and ensure we continue to provide the best support to researchers. Brian, Sarah and I have significant subject matter experience, all with strong scientific backgrounds, which is essential when joining such a credible team, driven by technical expertise and depth of knowledge.\u201d<\/em> <\/em><\/p>\n

Dr. Brian Manning, US Head of Sales, CN Bio, said: <\/strong>\u201cFollowing the Company\u2019s recent successful fundraising round, CN Bio is taking all opportunities to strengthen its position in the US, and support our customer base, internationally. In doing so, we can meet the growing demand for innovative organ-on-chip systems, in order to enhance the development of tomorrow’s medicines.\u201d<\/em><\/p>\n

Dr. Sarah Payne, Product Marketing Manager, CN Bio, commented<\/strong>: \u201cIt is exciting to be joining CN Bio at this pivotal stage of growth. Over the past ten years, the Company has honed its technically advanced organ-on-chip platforms and services to deliver high quality human-relevant data that can be relied upon. In my new role I look forward to promoting widespread awareness for CN Bio\u2019s innovative products and services within the life sciences. With an urgent market need for new in vitro tools that better predict clinical outcomes, it is a privilege to be working for a company whose potential to make a difference is so great.\u201d<\/em> <\/em><\/p>\n

For more information about CN Bio, please visit: https:\/\/cn-bio.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Appointments include James Craven as Chief Commercial Officer and Brian Manning as US Head of Sales Cambridge, UK, 05 August 2020: CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced the appointments of James Craven as Chief […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"content-sidebar","footnotes":""},"categories":[6],"tags":[],"class_list":{"0":"post-3535","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-press-release","7":"entry"},"acf":[],"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"CN Bio","author_link":"https:\/\/cn-bio.com\/author\/cn-bio\/"},"_links":{"self":[{"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/posts\/3535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/comments?post=3535"}],"version-history":[{"count":0,"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/posts\/3535\/revisions"}],"wp:attachment":[{"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/media?parent=3535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/categories?post=3535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cn-bio.com\/wp-json\/wp\/v2\/tags?post=3535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}